Powered by Google

A noncontrolled trial of anti-TNF-α chimeric monoclonal antibody (infliximab, Remicade(®) ) in exudative age-related macular degeneration.

Acta Ophthalmol 2014, vol. 92, issue 8

By visiting eyehospital.nl you are accepting the use of cookies. Read more about cookies.

Hide this message